Nanoscaled biosensors: reading epigenetic signatures to improve breast cancer detection and treatment (2008-2011)
Abstract
Due to limitations with current diagnostic and prognostic tools, many breast cancer patients are subjected to unnecessary adjuvant therapies, while others relapse and die despite having been treated according to state-of-the-art clinical guidelines. This situation indicates a need for a novel and innovative technology to develop clinically useful prognostic tools. This project seeks to address this by developing nanoscaled biosensors for breast cancer.
